It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Autophagy-mediated degradation of synaptic components maintains synaptic homeostasis but also constitutes a mechanism of neurodegeneration. It is unclear how autophagy of synaptic vesicles and components of presynaptic active zones is regulated. Here, we show that Pleckstrin homology containing family member 5 (Plekhg5) modulates autophagy of synaptic vesicles in axon terminals of motoneurons via its function as a guanine exchange factor for Rab26, a small GTPase that specifically directs synaptic vesicles to preautophagosomal structures. Plekhg5 gene inactivation in mice results in a late-onset motoneuron disease, characterized by degeneration of axon terminals. Plekhg5-depleted cultured motoneurons show defective axon growth and impaired autophagy of synaptic vesicles, which can be rescued by constitutively active Rab26. These findings define a mechanism for regulating autophagy in neurons that specifically targets synaptic vesicles. Disruption of this mechanism may contribute to the pathophysiology of several forms of motoneuron disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany; Department of Cell Biology, University of Bielefeld, Bielefeld, Germany
2 Department of Neurobiology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
3 Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
4 Department of Cell Biology, University of Bielefeld, Bielefeld, Germany
5 Department of Neurology, Hannover Medical School, Hannover, Germany
6 Department of Neurology, University Hospital Würzburg, Würzburg, Germany
7 Institut für Biochemie, Christian-Albrechts-Universität zu Kiel, Kiel, Germany
8 Cardeza Vascular Biology Center, Departments of Medicine and Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
9 Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
10 Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark
11 Department of Neurology, Hannover Medical School, Hannover, Germany; Integrated Research and Treatment Center Transplantation (IFB-Tx) Hannover, Hannover Medical School, Hannover, Germany
12 Department of Cell Biology, University of Bielefeld, Bielefeld, Germany; Molecular Neurobiology, University of Bielefeld, Bielefeld, Germany